BioNTech a buy at Wainwright, but price target lowered on long-term vaccine sales

2
Comment
Favorite

BioNTech a buy at Wainwright, but price target lowered on long-term vaccine sales

seekingalpha2022-02-24

Thomas Lohnes/Getty Images News H.C. Wainwright is maintaining its buy rating on BioNTech (BNTX -3.5%), but is lowering its price target due to concerns on long-term sales of the company's COVID-19 ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2213875992?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-02-24 01:15","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2213875992","market":"us","top_or_hot":-1,"title":"BioNTech a buy at Wainwright, but price target lowered on long-term vaccine sales","media":"seekingalpha","content":"<div>\n<p>Thomas Lohnes/Getty Images News   H.C. Wainwright is maintaining its buy rating on BioNTech (BNTX -3.5%), but is lowering its price target due to concerns on long-term sales of the company's COVID-19 ...</p>\n\n<a href=\"https://seekingalpha.com/news/3804324-biontech-a-buy-at-wainwright-but-price-target-lowered-on-long-term-vaccine-sales\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech a buy at Wainwright, but price target lowered on long-term vaccine sales</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech a buy at Wainwright, but price target lowered on long-term vaccine sales\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-24 01:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3804324-biontech-a-buy-at-wainwright-but-price-target-lowered-on-long-term-vaccine-sales><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Thomas Lohnes/Getty Images News   H.C. Wainwright is maintaining its buy rating on BioNTech (BNTX -3.5%), but is lowering its price target due to concerns on long-term sales of the company's COVID-19 ...</p>\n\n<a href=\"https://seekingalpha.com/news/3804324-biontech-a-buy-at-wainwright-but-price-target-lowered-on-long-term-vaccine-sales\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://seekingalpha.com/news/3804324-biontech-a-buy-at-wainwright-but-price-target-lowered-on-long-term-vaccine-sales","article_id":"2213875992","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2213875992","pubTimestamp":1645636541,"columns":[],"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Thomas Lohnes/Getty Images News   H.C. Wainwright is maintaining its buy rating on BioNTech (BNTX -3","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BNTX":"BioNTech SE","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4007":"制药","PFE":"辉瑞","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓","BK4534":"瑞士信贷持仓"},"translate_title":"BioNTech在温赖特收购，但长期疫苗销售的价格目标下调","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BNTX":0.9,"PFE":0.81},"content_text":"Thomas Lohnes/Getty Images News   H.C. Wainwright is maintaining its buy rating on BioNTech (BNTX -3.5%), but is lowering its price target due to concerns on long-term sales of the company's COVID-19 vaccine.  The firm now has a price target of $339, down from $366 (~126% upside based on Tuesday's close). \"While we believe that continuing expansion of vaccine authorizations into younger populations, the continued deployment of booster vaccines due to waning anti-SARSCoV-2 vaccine-induced immunity over time, and the possible near-term availability of an Omicron-specific vaccine may all buoy vaccine sales near-term, the possibility of transition to endemic status for the COVID-19 pandemic poses a long-term risk to the Comirnaty franchise because this may reduce population willingness to endure frequent vaccine shots,\" said analyst Robert Burns. While the demand for the shots, which are marketed with partner Pfizer (PFE -0.4%), may still persist as the pandemic enters the endemic stage, it could became substantially lower, he added. Read why Seeking Alpha contributor Edmund Ingham just wrote that BioNTech (BNTX -3.5%) is a sell.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}